Read More 2 minute read Clinical News News Pharmaceutical Vertex Advances Kidney Disease Drug into Phase 3 Trial Key Highlights Inaxaplin enters Phase 3 of its pivotal trial, focusing on AMKD patients, including adolescents aged 10 to… byChris-Anne RoqueApril 2, 2024